Obio Technology (Shanghai) Future Growth
Future criteria checks 2/6
Obio Technology (Shanghai) is forecast to grow earnings and revenue by 61.1% and 22.8% per annum respectively. EPS is expected to grow by 38.2% per annum. Return on equity is forecast to be -3.8% in 3 years.
Key information
61.1%
Earnings growth rate
38.2%
EPS growth rate
| Life Sciences earnings growth | 31.7% |
| Revenue growth rate | 22.8% |
| Future return on equity | -3.8% |
| Analyst coverage | Low |
| Last updated | 01 Sep 2024 |
Recent future growth updates
Recent updates
After Leaping 26% Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) Shares Are Not Flying Under The Radar
Nov 15
Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) Looks Just Right With A 27% Price Jump
Oct 01Some Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) Shareholders Look For Exit As Shares Take 27% Pounding
Apr 21Subdued Growth No Barrier To Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) With Shares Advancing 30%
Mar 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 413 | -15 | -69 | 121 | 2 |
| 12/31/2025 | 338 | -138 | -289 | -127 | 2 |
| 12/31/2024 | 271 | -176 | -236 | -65 | 2 |
| 9/30/2024 | 252 | -247 | -390 | -143 | N/A |
| 6/30/2024 | 234 | -196 | -426 | -142 | N/A |
| 3/31/2024 | 234 | -138 | -465 | -120 | N/A |
| 12/31/2023 | 205 | -128 | -637 | -90 | N/A |
| 9/30/2023 | 213 | -66 | -730 | -56 | N/A |
| 6/30/2023 | 240 | -26 | -756 | -35 | N/A |
| 3/31/2023 | 249 | -5 | -672 | 18 | N/A |
| 12/31/2022 | 291 | 39 | -463 | 21 | N/A |
| 9/30/2022 | 306 | 59 | -221 | 83 | N/A |
| 6/30/2022 | 291 | 59 | -170 | 82 | N/A |
| 3/31/2022 | 281 | 57 | -266 | 57 | N/A |
| 12/31/2021 | 255 | 54 | -153 | 109 | N/A |
| 9/30/2021 | 231 | 52 | -148 | 78 | N/A |
| 12/31/2020 | 143 | 94 | -34 | 62 | N/A |
| 12/31/2019 | 63 | -37 | -59 | -23 | N/A |
| 6/30/2019 | 52 | -38 | -65 | -21 | N/A |
| 3/31/2019 | 47 | -33 | -62 | -12 | N/A |
| 12/31/2018 | 44 | -32 | -58 | -1 | N/A |
| 9/30/2018 | 39 | -23 | -52 | -6 | N/A |
| 6/30/2018 | 35 | -18 | N/A | -10 | N/A |
| 3/31/2018 | 31 | -19 | N/A | -12 | N/A |
| 12/31/2017 | 28 | -20 | N/A | -14 | N/A |
| 9/30/2017 | 25 | -14 | N/A | -9 | N/A |
| 6/30/2017 | 23 | -9 | N/A | -4 | N/A |
| 3/31/2017 | 21 | -8 | N/A | -3 | N/A |
| 12/31/2016 | 20 | -7 | N/A | -2 | N/A |
| 12/31/2015 | 14 | -1 | N/A | 2 | N/A |
| 12/31/2014 | 8 | -4 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688238 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 688238 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 688238 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 688238's revenue (22.8% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688238's revenue (22.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688238 is forecast to be unprofitable in 3 years.